Statistical considerations in bioequivalence of two area under the concentration-time curves obtained from serial sampling data
From MaRDI portal
Publication:5129002
Recommendations
- Statistical considerations in bioequivalence trials
- The multivariate assessment of bioequivalence
- Analysis of multiple-dose bioequivalence studies
- A two one-sided tests procedure for assessment of individual bioequivalence
- Determining average bioequivalence and corresponding sample sizes in general asymmetric settings
Cites work
- scientific article; zbMATH DE number 3866349 (Why is no real title available?)
- scientific article; zbMATH DE number 3092162 (Why is no real title available?)
- A MULTIVARIATE TEST WITH COMPOSITE HYPOTHESES DETERMINED BY LINEAR INEQUALITIES WHEN THE COVARIANCE MATRIX HAS AN UNKNOWN SCALE FACTOR
- A special case of a bivariate non-central t-distribution
- APPROXIMATE SAMPLE SIZES FOR TESTING HYPOTHESES ABOUT THE RATIO AND DIFFERENCE OF TWO MEANS
- Bioequivalence trials, intersection-union tests and equivalence confidence sets. With comments and a rejoinder by the authors
Cited in
(4)- Comparative test of two groups for concentration-time curves
- OPTIMAL SAMPLING TIMES IN BIOEQUIVALENCE TESTS
- Optimal selection procedures for abbreviated area under the curve (aauc) of blood concentration versus time for drug blood concentration levels
- Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling
This page was built for publication: Statistical considerations in bioequivalence of two area under the concentration-time curves obtained from serial sampling data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5129002)